FindTrial
Sign In

A medical records based study for comparison of surgical outcomes between laparoscopic cholecystectomy with common bile duct exploration and endoscopic retrograde cholangiopancreatography endoscopic sphincterotomy followed by laparoscopic cholecystectomy for cholecysto-choledocholithiasis: A retrospective and propensity score matched study

Comparison of surgical outcomes between laparoscopic cholecystectomy with common bile duct exploration and endoscopic retrograde cholangiopancreatography endoscopic sphincterotomy followed by laparoscopic cholecystectomy for cholecysto-choledocholithiasis: A retrospective and propensity score matched study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037590
Enrollment
Unknown
Registered
2020-08-29
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Concomitant gallbladder stones and common bile duct stones

Interventions

LCBDE+LC group:LCBDE+LC
pre-ERCP+LC group:pre-ERCP+LC

Sponsors

The First Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 89 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-89 years-old; (2) Baseline laboratory examination: ALT or AST =100x10*9/L; (3) Gallstones and CBD stones diagnosed preoperatively with radiographic evidence; (4) Diameter of CBD is 0.8-2.5cm, CBD stones are between 0.8 and 2.5cm indicated by CT or MRCP; (5) The ERCP or surgical indications are unequivocal without contraindications (ASA score); (6) Have never accepted surgical treatment of right upper quadrant before.

Exclusion criteria

Exclusion criteria: (1) Radiologic evidence of large stones in common bile duct (>2.5 cm); (2) History of bleeding disorder;Haemophilia or bleeding tendency; treatment with anticoagulant therapy; (3) Evidence on ultrasonography (US) or computed tomography (CT) of an intrahepatic gallbladder, cirrhosis, liver mass or abscess, combining with intrahepatic duct stones or periampullary tumor; (4) Clinical or US/CT evidence of suppurative or necrotizing cholecystitis, gallbladder empyema, or perforation; multiple prior upper quadrant laparotomies; (5) Morbid obesity (BMI>40.0); (6) Female patients who are pregnant, within 28 days of postparturition or breast feeding; (7) Requirement for continuous immunosuppressant treatment or systemic corticosteroid; (8) Severe interstitial pneumonia, pulmonary fibrosis or severe emphysema; (9) Uncontrolled diabetes mellitus; (10) Severe systemic organ dysfunction (chronic liver, renal or heart diseases); (11) HIV positive; (12) ASA score >4; (13) patients who underwent ERCP alone without subsequent LC.

Design outcomes

Primary

MeasureTime frame
Surgical/Technical success rate;CBD stones clearance success rate;—

Secondary

MeasureTime frame
30-day mortality or in-hospital mortality;Hospital stay;Total charge;Operative time;—

Countries

China

Contacts

Public ContactChunlin Ge

The First Affiliated Hospital of China Medical University

gechunlin@139.com+86 13998303666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026